- Fully enrolled NANOPULSE-AF US IDE pivotal study for cardiac catheter system
- Cash, cash equivalents, and marketable securities totaled $189M
- GAAP R&D expenses increased to ~$16.8M for the quarter vs ~$11.3M prior year
Signal #149995 · SEC 8-K
$PLSE SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $PLSE filing catalyst
Why did $PLSE trigger an AI stock catalyst alert?
$PLSE triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +1.5/10). Headline: Pulse Biosciences Reports Q3 Results, Completes IDE Study Enrollment. Key points: - Fully enrolled NANOPULSE-AF US IDE pivotal study for cardiac catheter system - Cash, cash equivalents, and marketable securities totaled $189M - GAAP R&D expenses increased to ~$16.8M for the quarter vs ~$11.3M prior year
How did $PLSE stock react after the SEC filing?
After the SEC 8-K for $PLSE, observed market reaction: T0 price $53.07. Past moves do not guarantee future results.
Where can I get real-time $PLSE SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $PLSE via Telegram and the VIP Web Terminal from €10/month.